Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 144
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00870532 | Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT03188159 | Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer | ||
| NCT01716689 | Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas | ||
| NCT07241715 | Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE) | ||
| NCT04014309 | Accessible Cancer Care to Enable Support for Survivors Programme | ||
| NCT03792867 | Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma | ||
| NCT04946968 | Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers | ||
| NCT04072107 | EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) | ||
| NCT00687648 | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | ||
| NCT02313298 | Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer | ||
| NCT04632173 | Head and Neck cancERs International cOviD-19 collabOraTion | ||
| NCT04961632 | Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376 | ||
| NCT00263484 | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma | ||
| NCT07209501 | Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT) | ||
| NCT02368860 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma | ||
| NCT05516628 | Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma | ||
| NCT01570296 | A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR | ||
| NCT05957068 | Breast Cancer Exercise Intervention Study | ||
| NCT04118114 | Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors | ||
| NCT05059340 | Study to Explore Post Surgical Outcomes Using Point-of-Gaze, Electromyography and Elastography of the SCM | ||
| NCT04961489 | Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes | ||
| NCT04242251 | Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study | ||
| NCT07234357 | Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia | ||
| NCT04660188 | Impact of a Breast cAncer Survivorship Interprofessional Community Care Model | ||
| NCT06044441 | Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG) | ||
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | ||
| NCT03212807 | Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL | ||
| NCT01135056 | Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) | ||
| NCT07428655 | Acceptability and Feasibility of PSC Model of Serious Illness Communication | ||
| NCT04956068 | PIPAC for Peritoneal Metastases | ||
| NCT03097939 | Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma | ||
| NCT05773092 | A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC | ||
| NCT07166367 | Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer | ||
| NCT03330509 | Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital | ||
| NCT07111130 | Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer | ||
| NCT04664829 | The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | ||
| NCT04452084 | Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT | ||
| NCT03422432 | Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases | ||
| NCT01736410 | A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | ||
| NCT03711422 | Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC | ||
| NCT04269967 | A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors | ||
| NCT04620954 | Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin | ||
| NCT05286437 | Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole | ||
| NCT04303403 | Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma | ||
| NCT01540110 | Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses | ||
| NCT02412267 | Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) | ||
| NCT04912765 | Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC | ||
| NCT03212937 | Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma | ||
| NCT02931864 | Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors | ||
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors |
